What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion - WSJ What’s News

Summary5 min read

WSJ What’s News: Detailed Summary of "Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion"

Podcast Information

Title: WSJ What’s News
Host/Author: The Wall Street Journal
Episode: What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion
Release Date: April 19, 2025

The Wall Street Journal’s “What’s News” podcast delivers concise and insightful updates on the most significant developments in business, finance, and global markets. In this episode, host Francesca Fontana delves into notable stock movements, pivotal economic news, and strategic ambitions of major corporations shaping the market landscape.

Weekly Market Overview

Francesca Fontana opens the episode by summarizing the week’s market performance and key economic drivers:

Stock Market Performance:
- S&P 500: Decreased by 1.5%
- Dow Jones Industrial Average: Fell by 2.7%
- Nasdaq Composite: Dropped by 2.6%
Key Influences:
- Early week stability was disrupted by tariff concerns impacting the semiconductor industry on Wednesday, which exerted downward pressure on tech stocks.
- A significant factor was Fed Chair Jerome Powell’s warning about the potential economic repercussions of President Trump’s trade war. Powell stated at [02:35], “There is a strong likelihood that our economy will take a hit from ongoing trade tensions.”
Sector-Specific Movements:
- Dow Jones: Experienced notable declines influenced by UnitedHealth’s disappointing earnings, highlighting the sensitivity of the Dow’s price-weighted index to major components.

Francesca concludes the overview by noting the overall bearish trend for the week, intensified by external economic pressures and corporate earnings reports.

Eli Lilly’s Stock Surge Amid Weight Loss Pill Success

One of the standout stories of the week is the remarkable performance of Eli Lilly, a pharmaceutical giant competing in the lucrative weight loss medication market.

Context:
- Eli Lilly, alongside Novo Nordisk, dominates the obesity treatment sector with injectable drugs like Zepbound and Wegovy.
- The market for weight loss drugs is projected to reach $100 billion by 2030, signaling significant growth potential.
Recent Developments:
- On Thursday, Eli Lilly announced that its daily pill successfully met trial goals for lowering blood sugar and aiding weight loss in diabetics. This marks the initial results from several studies slated for this year.
Market Reaction:
- Investors responded enthusiastically to the positive trial outcomes, resulting in a 14% surge in Lilly’s shares on Thursday.

Francesca Fontana highlights this achievement as a pivotal moment for Eli Lilly, positioning the company as a front-runner in the expanding weight loss medication market.

UnitedHealth’s Sharp Decline Due to Disappointing Earnings

In stark contrast to Eli Lilly’s upswing, UnitedHealth experienced a significant drop in its stock price, affecting the broader market index.

Company Overview:
- UnitedHealth is a leading healthcare conglomerate and the parent company of UnitedHealthcare, the largest health insurer in the United States.
Earnings Report:
- The company slashed its annual outlook and reported quarterly earnings that fell short of Wall Street’s expectations.
- Francesca notes at [08:42], “This is a rare stumble for UnitedHealth, which typically delivers a steady stream of increased earnings and better-than-projected financial performance.”
Reason for Disappointment:
- The downturn was primarily due to higher than expected medical costs in its Medicare business. While rising medical expenses have been an industry-wide issue over the past year, they had not previously impacted UnitedHealth to this extent.
Impact on Stock:
- The combination of lowered outlook and missed earnings targets led to a 22% plunge in UnitedHealth’s stock on Thursday.
- This sharp decline had a disproportionate effect on the Dow Jones Industrial Average, given UnitedHealth’s weight in the price-weighted index.

Francesca emphasizes the significance of this event, as it underscores the challenges faced by even the most robust companies in navigating unexpected cost pressures.

Netflix’s Ambitious Goal to Reach a $1 Trillion Market Cap

Shifting focus to the entertainment sector, Netflix has unveiled its bold strategic objectives, aiming to solidify its position among the world’s most valuable companies.

Strategic Goals:
- Market Capitalization: Netflix aspires to join the elite group of companies with a market cap exceeding $1 trillion, a club currently inhabited by tech giants like Apple and Nvidia.
- Revenue Growth: The company aims to double its revenue to approximately $80 billion by 2030.
Current Standing:
- As of the episode’s release, Netflix boasts a market cap of over $400 billion.
- Recent strategies contributing to growth include price increases, limiting password sharing, and the introduction of an advertising business.
Market Resilience:
- Unlike many tech companies, Netflix has remained relatively unaffected by the market volatility stemming from Trump’s tariff policies.
- Francesca reports at [15:10], “Netflix shares gained 4.8% on Tuesday and, on a weekly basis, rose about 6%.”
Upcoming Financials:
- Netflix is set to release its latest quarterly results after market close on Thursday, which are anticipated to showcase a record quarterly profit.
- Although the market was closed on Friday, indicating limited immediate trading opportunities, the positive momentum suggests continued investor interest.

Francesca underscores Netflix’s resilience and strategic initiatives as key factors propelling its pursuit of a $1 trillion valuation.

Conclusion and Further Insights

In wrapping up the episode, Francesca Fontana directs listeners to additional resources for more comprehensive coverage:

Further Reading: Interested listeners can explore more about the week’s stock movements and in-depth analyses in Francesca’s column, “The Score,” featured in the Wall Street Journal’s Exchange section.
Production Credits: The episode was produced by Zoe Kolkin and Anthony Banci, with supervising producer Talia Bell.

Final Remarks: Francesca concludes by wishing listeners a great weekend, reinforcing the podcast’s role as a reliable source for staying informed about the dynamic world of markets and business.

Notable Quotes:

Jerome Powell on Trade War Impact: “[02:35] There is a strong likelihood that our economy will take a hit from ongoing trade tensions.”
Francesca Fontana on UnitedHealth's Performance: “[08:42] This is a rare stumble for UnitedHealth, which typically delivers a steady stream of increased earnings and better-than-projected financial performance.”
Francesca Fontana on Netflix’s Market Position: “[15:10] Netflix shares gained 4.8% on Tuesday and, on a weekly basis, rose about 6%.”

This episode of WSJ What’s News provides a comprehensive overview of significant market movements and corporate developments, offering listeners a nuanced understanding of the factors influencing today’s financial landscape.

Loading summary

Transcript2 lines

[00:00]
A
Spring savings are in the air. And at Ross, where they have savings on all the brands you love, from the latest fashion to outdoor decor and even pet supplies, savings are in every aisle. Go to ross and save 20 to 60% off other retailers prices on your favorite spring finds.
[00:18]
B
Hey listeners, it's Saturday, April 19th. I'm Francesca Fontana for the Wall Street Journal, and this is what's news in markets. Our look at the biggest stock moves of the week and the news that drove them. Let's get to after some relative calm earlier in the week, the tariff angst came for the chip industry on Wednesday and ended up weighing down tech stocks. Also turning stocks lower was a warning from Fed Chair Jerome Powell, who said there was a strong likelihood that the economy would take a hit from President Trump's trade war. The Dow was also dragged down Thursday by disappointing results from UnitedHealth, with the Healthcare bellwether's share price having an outsized effect on the price weighted index. But more on that in a bit. And Friday, as you likely noticed, the stock market was closed for good Friday. On the week, The S&P 500 lost 1.5%, the Dow fell 2.7%, and the Nasdaq fell 2.6%. First up, let's talk about some big movers outside of all the tariff drama, like Eli Lilly, one of the drug makers vying for the lead in the race for a weight loss pill. A little context. Pharmaceutical companies including Lilly and Novo Nordisk, which currently dominate the obesity market with injectable drugs like Zepbound and Wegovy, have been testing pills that could help people lose weight. The market for weight loss drugs has been on fire, and analysts say it could reach $100 billion by the end of the decade. On Thursday, Lilly said its daily pill met its goals in a trial helping diabetics lower their blood sugar and lose weight. And these results are the first from several studies of the pill expected this year. And they were certainly celebrated by investors because Lilly shares surged 14% on Thursday. Now let's circle back to UnitedHealth, the healthcare conglomerate and parent of UnitedHealthcare, America's largest health insurer. UnitedHealth's stock took a nosedive on Thursday after the company slashed its annual outlook and posted quarterly earnings that fell short of Wall Street's expectations. This is a rare stumble for the company. You know, it typically delivers a steady stream of increased earnings and better than projected financial performance. So what caused the unexpectedly disappointing results? Well, higher than expected medical costs in its Medicare business. This is an issue that has affected the entire industry over the past year, but until now, it's been not so significant a problem. At UnitedHealth, the stock ended up plummeting 22% on Thursday. Last but not least, some news from Netflix. The streaming giant has some pretty ambitious goals, the Wall Street Journal reported this week, including joining the elite club of companies with a market cap of $1 trillion or more, which includes tech giants like Apple and Nvidia. The company also aims to double its revenue to about $80 billion by 2030. So where's Netflix at right now? Well, it's got a market cap of more than $400 billion, for starters, and the company has boosted its performance in recent years by raising prices, limiting password sharing and starting an ad business. Another thing Netflix has going for it it's been relatively unscathed by the market turmoil related to Trump's tariffs, at least so far. Netflix shares gained 4.8% Tuesday and on a weekly basis rose about 6%. We also got the latest quarterly results from Netflix later in the week after market close on Thursday, in which it reported a record quarterly profit. But as we know, the market was closed on Friday, so the stock is definitely one to keep an eye on Monday. And now you know what's news in markets this week. You can read about more stocks that moved on the week's news in the Score, my column in the Wall Street Journal's Exchange section. Today's show was produced by Zoe Kolkin and Anthony Banci, with supervising producer Talia Bell. I'm Francesca Fontana. Have a great weekend and see you next.